Skip to main content

Advertisement

SpringerLink
Log in

Treatment of erectile dysfunction following spinal cord injury

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Spinal cord injury (SCI) has a significant impact on erectile dysfunction. Treatment modalities for individuals with SCI are similar to treatments for those without SCI. Some of the most common methods of management include penile implants, oral phosphodiesterase (PDE) inhibitors, vacuum devices, intraurethral prostaglandins, and intracavernous injections. In addition to the advantages and disadvantages of these various modalities for able-bodied men, there are special considerations for men with SCI. Penile implants may help to keep an external condom catheter in place and provide more penile stability for intermittent catheterization. However, they have an increased risk of infection. Semirigid rods have an increased risk of erosion. Although convenient to use, PDE inhibitors are usually not effective in lower motor injuries. The hypotensive effects of intraurethral prostaglandins and PDE inhibitors need to be considered in SCI men with injuries at or above T6. Intracavernous injections are very effective; however, men with SCI require much lower doses than able-bodied men.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Fisher TL, Laud PW, Byfield MG, et al.: Sexual health after spinal cord injury: a longitudinal study. Arch Phys Med Rehabil 2002, 83:1043–1051.

    Article  PubMed  Google Scholar 

  2. Saenz de Tejada I, Goldstein I, Krane KJ: Local control of penile erection: nerves, smooth muscle, and endothelium. Urol Clin N Am 1988, 15:9–15.

    CAS  Google Scholar 

  3. Comarr AE: Sexual function among patients with SCI. Urol Int 1970, 25:134–168.

    CAS  PubMed  Google Scholar 

  4. Bors E, Comarr AE: Neurological disturbances of sexual function with special reference to 529 patients with spinal cord injury. Urol Surv 1960, 10:191–222.

    Google Scholar 

  5. Talbot HS: The sexual function in paraplegia. J Urol 1955, 73:91.

    CAS  PubMed  Google Scholar 

  6. Comarr AE: Sexual function among the patients with spinal cord injury. Urol Int 1970, 25:134–168.

    Article  CAS  PubMed  Google Scholar 

  7. Phelps J, Albo M, Dunn K, Joseph A: SCI and sexuality in married and partnered men. Arch Sexual Behav 2001, 30:591–602.

    Article  CAS  Google Scholar 

  8. Deforge D, Blackmer J, Moher D, et al.: Sexuality and reproductive health following SCI. Review. Evid Rep Technol Assess (Summ) 2004, 109:1–8.

    Google Scholar 

  9. Ekrem FP, Hanson TJ, Merritt JL, Barrett DM: Efficacy of penile prosthesis in spinal cord injured patients. Am Spinal Inj Assoc Abstract Digest 1987, 188–192.

  10. Kimoto Y, Iwatsubo E: Penile prosthesis for the management of the neuropathic bladder and sexual dysfunction in spinal cord injury patients: long term follow up. Paraplegia 1994, 32:336–339.

    CAS  PubMed  Google Scholar 

  11. Zermann DH, Kutzenberger J, Sauerwein D, et al.: Penile prosthetic surgery in neurologically impaired patients: long term follow up. J Urol 2006, 175:1041–1044; discussion 1044.

    Article  PubMed  Google Scholar 

  12. Small MP: Small-Carrion penile prosthesis. A new implant for the management of impotence. Mayo Clinic Proc 1976, 51:336–338.

    CAS  Google Scholar 

  13. Perkash I, Kabalin JN, Lennon S, Wolfe V: Use of penile prosthesis to maintain external condom catheter drainage in spinal cord injured patients. Paraplegia 1992, 30:327–332.

    CAS  PubMed  Google Scholar 

  14. Iwatsubo E, Tanake M, Takahashi K, Akatsu T: Non inflatable penile prosthesis for the management of urinary incontinence and sexual disability of patients with spinal cord injury. Paraplegia 1986, 24:307–310.

    CAS  PubMed  Google Scholar 

  15. Denil J, Ohl DA, Smythe C: Vacuum erection device in spinal cord injured men: patient and partner satisfaction. Arch Phys Med Rehabil 1996, 77:750–753.

    Article  CAS  PubMed  Google Scholar 

  16. Moemen MN, Fahmy I, Abdelaal M, et al.: Erectile dysfunction in spinal cord injured men: different treatment options. Int J Impot Res 2008, 20:181–187.

    Article  CAS  PubMed  Google Scholar 

  17. Broderick GA, McGahan JP, Stone AR, White R: The hemodynamics of vacuum constriction erections: assessment by color Doppler ultrasound. J Urol 1992, 147:57–61.

    CAS  PubMed  Google Scholar 

  18. Rivas DA, Chancellor MB: Complications associated with the use of vacuum constriction devices for erectile dysfunction in the spinal cord injured population. J Am Paraplegia Soc 1994, 17:136–139.

    CAS  PubMed  Google Scholar 

  19. Padma-Nathan H, Hellstrom WJ, Kaiser FE: Treatment of men with erectile dysfunction with transurethral alprostadil: Medicated Urethral System For Erection (MUSE) study. N Engl J Med 1997, 336:1–7.

    Article  CAS  PubMed  Google Scholar 

  20. Bodner DR, Haas CA, Krueger B, Seftel AD: Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury. Urology 1999, 53:199–202.

    Article  CAS  PubMed  Google Scholar 

  21. Burnett AL: The role of nitric oxide in the physiology of erection. Biol Reprod 1995, 52:485–489.

    Article  CAS  PubMed  Google Scholar 

  22. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ: Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996, 78:257–261.

    CAS  PubMed  Google Scholar 

  23. Derry FA, Dinsmore WW, Fraser M, et al.: Efficacy and safety of oral sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord injury. Neurology 1998, 51:1629–1633.

    CAS  PubMed  Google Scholar 

  24. Giuliano F, Hultling C, Wagih S, et al.: Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury. Ann Neurol 1999, 46:15–21.

    Article  CAS  PubMed  Google Scholar 

  25. Derry F, Hultling C, Seftel AD, Sipski ML: Efficacy and safety of sildenafil citrate (Viagra) in men with erectile dysfunction and spinal cord injury. A review. Urology 2002, 60(Suppl 2B):49–57.

    Article  PubMed  Google Scholar 

  26. Schmid DM, Schurch B, Hauri D: Sildenafil in the treatment of sexual dysfunction in spinal cord injured male patients. Eur Urol 2000, 38:184–193.

    Article  CAS  PubMed  Google Scholar 

  27. Soler JM, Previnaire JG, Denys P, Chartier Kastler E: Phosphodiesterase inhibitors in the treatment of erectile dysfunction in spinal cord injured men. Spinal Cord 2007, 45:169–173.

    Article  CAS  PubMed  Google Scholar 

  28. Giuliano F, Rubrio-Aurioles E, Kenelly M, et al.: Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury. Neurology 2006, 66:210–216.

    Article  CAS  PubMed  Google Scholar 

  29. Del Popolo G, Li Marzi V, Mondaini N, Lombardi G: Time/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal cord injured patients. Spinal Cord 2004, 42:643–648.

    Article  PubMed  Google Scholar 

  30. Consortium of SCI Medicine: Acute management of autonomic dysreflexia. J Spinal Cord Med 2002, 25(Suppl 1):67–88.

  31. Illman A, Stiller K, Williams M: The prevalence of orthostatic hypotension during physiotherapy treatment in patients with an acute spinal cord injury. Spinal Cord 2000, 38:741–747.

    Article  CAS  PubMed  Google Scholar 

  32. Claydon VE, Steeves JD, Krassioukov A: Orthostatic hypotension following spinal cord injury: understanding clinical pathophysiology. Spinal Cord 2006, 44:341–351.

    Article  CAS  PubMed  Google Scholar 

  33. Maytom MC, Derry FA, Dinsmore WW, et al.: A two part pilot study of sildenafil (Viagra) in men with erectile dysfunction caused by spinal cord injury. Spinal Cord 1999, 37:110–116.

    Article  CAS  PubMed  Google Scholar 

  34. Sanchez Ramos A, Vidal J, Jáuregui ML, et al.: Efficacy, safety and predictive factors of therapeutic success with sildenafil for erectile dysfunction in patients with different spinal cord injuries. Spinal Cord 2002, 39:637–643.

    Article  Google Scholar 

  35. Garcia-Bravo AM, Suarez Hernandez D, Ruiz Fernandez MA, et al.: Determination of changes in blood pressure during administration of sildenafil (Viagra) in patients with spinal cord injury and erectile dysfunction. Spinal Cord 2006, 44:301–308.

    Article  CAS  PubMed  Google Scholar 

  36. Ethans KD, Casey AR, Schryvers OI, MacNeil BJ: Effects of sildenafil on the cardiovascular response in men with SCI at or above the sixth thoracic level. J Spinal Cord Med 2003, 26:222–226.

    PubMed  Google Scholar 

  37. Consortium for SCI Medicine: SCI bladder management for adults with spinal cord injury. J Spinal Cord Med 2006, 29:527–573.

  38. Virag R: Intracavernous injection of papaverine for erectile failure. Lancet 1982, 2:938.

    Article  CAS  PubMed  Google Scholar 

  39. Brindley GS: Cavernosal alpha blockade: a new technique for investigating and treating erectile impotence. Brit J Psychiat 1983, 143:2332–2337.

    Article  Google Scholar 

  40. Bodner DR, Lindan R, Leffler E, et al.: The application of intracavernous injection of vasoactive medications for erections in men with spinal cord injury. J Urol 1987, 138:310–311.

    CAS  PubMed  Google Scholar 

  41. Sidi AA, Cameron JS, Dykstra DD, et al.: Vasoactive intracavernous pharmacotherapy for the treatment of erectile impotence in men with spinal cord injury. J Urol 1987, 138:539–541.

    CAS  PubMed  Google Scholar 

  42. Lloyd Kl, Richards JS: Intracorporeal injections in spinal cord injury: two year follow up. Am Spinal Inj Assoc Abstract Digest 1990, 68.

  43. Kapoot VK, Chahal AS, Jyoti SP, et al.: Intracavernous papaverine for impotence in spinal cord injured patients. Paraplegia 1993, 31:675–677.

    Google Scholar 

  44. Wyndaele JJ, de Meyer JM, de Sy WA, Claessens H: Intracavernous injection of vasoactive drugs: one alternative for treating impotence in spinal cord injured patients. Paraplegia 1986, 24:271–275.

    CAS  PubMed  Google Scholar 

  45. Larsen EH, Gasser TC, Bruskewitz RC: Fibrosis of corpora cavernosum after intracavernous injections of phentolamine/papaverine. J Urol 1987, 137:59–62.

    Google Scholar 

  46. Levine SB, Althof SE, Turner LA, et al.: Side effects of self administered papaverine/phentolamine for the treatment of impotence. J Urol 1989, 141:54–57.

    CAS  PubMed  Google Scholar 

  47. Chao R, Clowers DE: Experience with intracavernosal Tri-Mixture for the management of neurogenic erectile dysfunction. Arch Phys Med Rehabil 1994, 75:276–278.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Kessler Institute for Rehabilitation, 1199 Pleasant Valley Way, West Orange, NJ, 07052, USA

    Todd A. Linsenmeyer

  2. Department of Surgery (Division of Urology) and Department of Physical Medicine and Rehabilitation, UMDNJ New Jersey Medical School, Newark, NJ, 07101, USA

    Todd A. Linsenmeyer

Authors
  1. Todd A. Linsenmeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Todd A. Linsenmeyer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Linsenmeyer, T.A. Treatment of erectile dysfunction following spinal cord injury. Curr Urol Rep 10, 478–484 (2009). https://doi.org/10.1007/s11934-009-0076-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-009-0076-x

Keywords

Search

Navigation